{
    "clinical_study": {
        "@rank": "116129", 
        "acronym": "ASCUS-COL", 
        "arm_group": [
            {
                "arm_group_label": "HPV test", 
                "arm_group_type": "Experimental", 
                "description": "Women with ASC-US cytology are HPV tested and those HPV positive are refer to Colposcopy"
            }, 
            {
                "arm_group_label": "COLPOSCOPY", 
                "arm_group_type": "Active Comparator", 
                "description": "Women with ASC-US cytology are immediately refer to colposcopy"
            }, 
            {
                "arm_group_label": "CYTOLOGY", 
                "arm_group_type": "Active Comparator", 
                "description": "Women with ASC-US Cytology are follow-up with cytology at 6 and/or 12 months and be referred to colposcopy if any of these cytologies is ASC-US or higher"
            }
        ], 
        "brief_summary": {
            "textblock": "Cervical cancer as well cervical preneoplastic abnormalities (CIN2+) are cause by human\n      papillomavirus (HPV) infection. These abnormalities have been historically detected by\n      cervical cytology, but recent evidence shows that HPV testing is superior to cytology to\n      detect cervical lesions that eventually will progress to cancer. Despite evidence,\n      conventional cytology (Pap) remains as a primary screening test in Colombia and HPV test is\n      recommended as a triage test for women with atypical squamous cells of undetermined\n      significance (ASC-US) in settings around the world. Women with ASC-US have low risk to CIN2+\n      but higher than healthy population, and therefore it is important to provide appropriate\n      clinical management."
        }, 
        "brief_title": "Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cervical Abnormalities", 
            "Cervical Intraepithelial Neoplasia Grade 2/3", 
            "Cervical Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Neoplasms", 
                "Uterine Cervical Neoplasms", 
                "Cervical Intraepithelial Neoplasia", 
                "Uterine Cervical Dysplasia", 
                "Carcinoma in Situ"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim of this study is to compare the effectiveness and efficiency of repeating\n      conventional cytology at 6/12 months (Cyt), having immediate colposcopy (Col) and being\n      triaged with HPV testing (QIAGEN-The digene HPV Test\u00ae) for the clinical management of women\n      with ASC-US insured in health care management organizations (HCMO) within the Colombian\n      health security system. This study is randomizing 3,000, 20-69 years old women with ASC-US,\n      insured in HCMOs in Medellin-Colombia, to 3 arms: Cyt, Col and HPV. All women are scheduled\n      for a visit at 2 years after recruitment that includes HPV test/cytology and colposcopy\n      either if HPV+ (RLU>=1) or abnormal cytology (>=ASC-US). This colposcopy is performed by a\n      trained colposcopist and women are followed-up according to a well-defined algorithm. The\n      fewer high-grade cervical neoplasia (CIN2+) rate at the end of following will determine the\n      most effective arm. The most efficiency arm will be which reach the major effective with the\n      minimum resources (cytologies, colposcopies and pathologies) consumed. The resources\n      consumed are being retrieved from the HCMOs. This study will allow us to know if within the\n      Colombian health security system, the HPV test will remain superior to repeating cytology\n      and/or to inmediate colposcopy as it has been demonstrated in randomized controlled trials\n      carried out in outside settings."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASC-US cytology, living in metropolitan area of Medellin\n\n        Exclusion Criteria:\n\n          -  Previous abnormal cytology"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02067468", 
            "org_study_id": "111545921657"
        }, 
        "intervention": [
            {
                "arm_group_label": "HPV test", 
                "description": "QIAGEN - The Digene HPV test\u00ae", 
                "intervention_name": "HPV test", 
                "intervention_type": "Device", 
                "other_name": [
                    "Human Papillomavirus test", 
                    "DNA HPV test", 
                    "High risk HPV test"
                ]
            }, 
            {
                "arm_group_label": [
                    "HPV test", 
                    "COLPOSCOPY", 
                    "CYTOLOGY"
                ], 
                "description": "Colposcopy routine health services", 
                "intervention_name": "COLPOSCOPY", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "CYTOLOGY", 
                "description": "Cytology routine health services", 
                "intervention_name": "cytology", 
                "intervention_type": "Device", 
                "other_name": [
                    "Pap smear", 
                    "Papanicolaou test", 
                    "cervical cytology"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Human Papillomavirus", 
            "cervical cancer", 
            "health services research", 
            "Colombia", 
            "Cervical Intraepithelial Neoplasia"
        ], 
        "lastchanged_date": "February 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Medellin", 
                    "country": "Colombia", 
                    "state": "Antioquia"
                }, 
                "name": "Universidad de Antioquia"
            }, 
            "investigator": {
                "last_name": "Gloria I Sanchez, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Colombia"
        }, 
        "number_of_arms": "3", 
        "official_title": "Evaluation of Strategies for Optimal Clinical Management of Women With Atypical Squamous Cells of Undetermined Significance (ASC-US)", 
        "overall_contact": {
            "email": "sanchezg@une.net.co", 
            "last_name": "Gloria I Sanchez, PhD", 
            "phone": "5742196066"
        }, 
        "overall_contact_backup": {
            "email": "mariaceciliaagudelo26@gmail.com", 
            "last_name": "Maria C Agudelo, MD", 
            "phone": "5742196063"
        }, 
        "overall_official": [
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Gloria I Sanchez, MSc, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Armando Baena, MSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Maria C Agudelo, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Alejandra Botero, MSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Victor Florez, MSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Calatina Villa, BSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Alina Valencia, BSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Astrid Bedoya, MSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "DINAMICA IPS", 
                "last_name": "Guadalupe Posada, MD, Esp", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "EPS COMFENALCO", 
                "last_name": "Carlos A Buitrago, MD, Esp", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "EPS COMFAMA", 
                "last_name": "Juan C Ochoa, MD, Esp", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "DINAMICA IPS", 
                "last_name": "Luis J Gomez, MD, Esp", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Maria E Mejia, BSc, Esp", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universidad de Antioquia", 
                "last_name": "Tatiana Ramirez, BSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "International Agency for Research on Cancer (IARC)", 
                "last_name": "Maribel Almonte, MSc, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "International Agency for Research on Cancer (IARC)", 
                "last_name": "Rolando Herrero, MSc, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Colombia: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Cervical Intraepithelial Neoplasia Grade 2 or higher(CIN2+)", 
            "safety_issue": "Yes", 
            "time_frame": "2 years after enrollment"
        }, 
        "reference": [
            {
                "PMID": "21351269", 
                "citation": "Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516."
            }, 
            {
                "PMID": "10451482", 
                "citation": "Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Mu\u00f1oz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12-9."
            }, 
            {
                "PMID": "12824967", 
                "citation": "ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003 Jun;188(6):1383-92."
            }, 
            {
                "PMID": "18670718", 
                "citation": "Andr\u00e9s-Gamboa O, Chica\u00edza L, Garc\u00eda-Molina M, D\u00edaz J, Gonz\u00e1lez M, Murillo R, Ballesteros M, S\u00e1nchez R. Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia. Salud Publica Mex. 2008 Jul-Aug;50(4):276-85."
            }, 
            {
                "PMID": "11015972", 
                "citation": "Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol. 2000 Sep-Oct;44(5):726-42."
            }, 
            {
                "PMID": "12873166", 
                "citation": "Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003 Aug;127(8):946-9. Review."
            }, 
            {
                "PMID": "16950021", 
                "citation": "Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006 Aug 31;24 Suppl 3:S3/78-89. Review."
            }, 
            {
                "PMID": "15593261", 
                "citation": "Carozzi FM, Confortini M, Cecchini S, Bisanzi S, Cariaggi MP, Pontenani G, Raspollini MR, Sani C, Zappa M, Ciatto S. Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment. Cancer. 2005 Feb 25;105(1):2-7."
            }, 
            {
                "PMID": "16399769", 
                "citation": "Legood R, Gray A, Wolstenholme J, Moss S. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ. 2006 Jan 14;332(7533):79-85. Epub 2006 Jan 6."
            }, 
            {
                "PMID": "16418511", 
                "citation": "Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ; ALTS Group. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst. 2006 Jan 18;98(2):92-100."
            }, 
            {
                "PMID": "17308921", 
                "citation": "Sheriff SK, Petry KU, Ikenberg H, Crouse G, Mazonson PD, Santas CC. An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in Germany. Eur J Health Econ. 2007 Jun;8(2):153-60. Epub 2007 Feb 17."
            }, 
            {
                "PMID": "20886598", 
                "citation": "Vanni T, Legood R, Franco EL, Villa LL, Luz PM, Schwartsmann G. Economic evaluation of strategies for managing women with equivocal cytological results in Brazil. Int J Cancer. 2011 Aug 1;129(3):671-9. doi: 10.1002/ijc.25708. Epub 2010 Nov 12."
            }, 
            {
                "PMID": "20824706", 
                "citation": "Dillner L, Kemetli L, Elfgren K, Bogdanovic G, Andersson P, Carlsten-Thor A, Andersson S, Persson E, Rylander E, Grillner L, Dillner J, T\u00f6rnberg S. Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities. Int J Cancer. 2011 Jul 1;129(1):151-9. doi: 10.1002/ijc.25649. Epub 2010 Nov 9."
            }, 
            {
                "PMID": "20846064", 
                "citation": "Ostensson E, Fr\u00f6berg M, Hjerpe A, Zethraeus N, Andersson S. Economic analysis of human papillomavirus triage, repeat cytology, and immediate colposcopy in management of women with minor cytological abnormalities in Sweden. Acta Obstet Gynecol Scand. 2010 Oct;89(10):1316-25. doi: 10.3109/00016349.2010.512066. Erratum in: Acta Obstet Gynecol Scand. 2010 Nov;89(11):1497."
            }, 
            {
                "PMID": "19567619", 
                "citation": "Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009 Aug 4;151(3):206-9. Epub 2009 Jun 30."
            }, 
            {
                "PMID": "23881840", 
                "citation": "Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M. Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types. Cancer Cytopathol. 2013 Dec;121(12):675-87. doi: 10.1002/cncy.21325. Epub 2013 Jul 23. Review."
            }, 
            {
                "PMID": "23199969", 
                "citation": "Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266."
            }, 
            {
                "PMID": "21918682", 
                "citation": "S\u00f8rbye SW, Arbyn M, Fismen S, Gutteberg TJ, Mortensen ES. Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology. PLoS One. 2011;6(8):e24083. doi: 10.1371/journal.pone.0024083. Epub 2011 Aug 30."
            }, 
            {
                "PMID": "19166485", 
                "citation": "Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med. 2009 Apr;13(4):648-59. doi: 10.1111/j.1582-4934.2008.00631.x. Epub 2009 Jan 23."
            }, 
            {
                "PMID": "18847555", 
                "citation": "Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019. Review."
            }, 
            {
                "PMID": "15859311", 
                "citation": "Dalla Palma P, Pojer A, Girlando S. HPV triage of women with atypical squamous cells of undetermined significance: a 3-year experience in an Italian organized programme. Cytopathology. 2005 Feb;16(1):22-6."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02067468"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universidad de Antioquia", 
            "investigator_full_name": "Gloria I. Sanchez, MSc, PhD", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Universidad de Antioquia", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "International Agency for Research on Cancer", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Barts and the London School of Medicine and Dentistry", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Instituto Colombiano para el Desarrollo de Ciencia y Tecnolog\u00eda COLCIENCIAS", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "QIAGEN Gaithersburg, Inc", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "EPS SURA", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "EPS COMFAMA", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "EPS COMFENALCO", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "DINAMICA IPS", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Laboratorio Cl\u00ednico Escuela de Microbiolog\u00eda (Universidad de Antioquia)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Metrosalud", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Universidad de Antioquia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}